Home › Compare › NEVPF vs ADC

NEVPF vs ADC: Dividend Comparison 2026

NEVPF yields 7142.86% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEVPF wins by $2020155342665731.00M in total portfolio value
10 years
NEVPF
NEVPF
● Live price
7142.86%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2020155342665731.25M
Annual income
$1,966,011,161,323,515,200,000.00
Full NEVPF calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — NEVPF vs ADC

📍 NEVPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEVPFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEVPF + ADC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NEVPF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEVPF
Annual income on $10K today (after 15% tax)
$607,142.86/yr
After 10yr DRIP, annual income (after tax)
$1,671,109,487,124,987,800,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, NEVPF beats the other by $1,671,109,487,124,987,800,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEVPF + ADC for your $10,000?

NEVPF: 50%ADC: 50%
100% ADC50/50100% NEVPF
Portfolio after 10yr
$1010077671332865.75M
Annual income
$983,005,580,661,757,600,000.00/yr
Blended yield
97.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

NEVPF
No analyst data
Altman Z
-0.7
Piotroski
2/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEVPF buys
0
ADC buys
0
No recent congressional trades found for NEVPF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEVPFADC
Forward yield7142.86% ✓4.11%
Annual dividend / share$2.00$3.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4% ✓
Portfolio after 10y$2020155342665731.25M ✓$176.9K
Annual income after 10y$1,966,011,161,323,515,200,000.00 ✓$79,647.25
Total dividends collected$2016528271361529.00M ✓$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: NEVPF vs ADC ($10,000, DRIP)

YearNEVPF PortfolioNEVPF Income/yrADC PortfolioADC Income/yrGap
1← crossover$724,986$714,285.71$10,987$577.21+$714.0K → NEVPF
2$49,172,645$48,396,910.17$12,293$855.34+$49.16M → NEVPF
3$3,120,421,331$3,067,806,600.72$14,088$1,290.70+$3120.41M → NEVPF
4$185,281,229,916$181,942,379,091.82$16,660$1,994.91+$185281.21M → NEVPF
5$10,294,691,143,508$10,096,440,227,497.77$20,525$3,181.85+$10294691.12M → NEVPF
6$535,299,070,050,255$524,283,750,526,701.75$26,654$5,286.90+$535299070.02M → NEVPF
7$26,050,796,629,539,330$25,478,026,624,585,550.00$37,006$9,259.47+$26050796629.50M → NEVPF
8$1,186,669,129,317,434,600$1,158,794,776,923,827,700.00$55,862$17,338.74+$1186669129317.38M → NEVPF
9$50,602,038,637,584,920,000$49,332,302,669,215,270,000.00$93,452$35,300.32+$50602038637584.83M → NEVPF
10$2,020,155,342,665,731,300,000$1,966,011,161,323,515,200,000.00$176,931$79,647.25+$2020155342665731.00M → NEVPF

NEVPF vs ADC: Complete Analysis 2026

NEVPF — Stock

Abliva AB (publ) develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Full NEVPF Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this NEVPF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEVPF vs SCHDNEVPF vs JEPINEVPF vs ONEVPF vs KONEVPF vs MAINNEVPF vs NNNNEVPF vs EPRTNEVPF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.